Literature DB >> 17426281

Cellular therapy for type 1 diabetes: has the time come?

Jay S Skyler.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17426281     DOI： 10.1001/jama.297.14.1599

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

Review 1.  Adult neural stem cells: response to stroke injury and potential for therapeutic applications.

Authors:  Basam Z Barkho; Xinyu Zhao
Journal:  Curr Stem Cell Res Ther       Date:  2011-12       Impact factor: 3.828

Review 2.  Stem cell researches in Brazil: present and future challenges.

Authors:  Mayana Zatz
Journal:  Stem Cell Rev Rep       Date:  2009-02-19       Impact factor: 5.739

3.  Residual β-Cell Function Predicts Clinical Response After Autologous Hematopoietic Stem Cell Transplantation.

Authors:  Hang Xiang; Chao Yang; Tianyuan Xiang; Zheng Wang; Xin Ge; Fan Li; Yuehan Su; Haixu Chen; Xianyong Huang; Qiang Zeng
Journal:  Stem Cells Transl Med       Date:  2016-03-29       Impact factor: 6.940

4.  Stem cell transplantation for type 1 diabetes mellitus.

Authors:  Júlio C Voltarelli; Carlos Eduardo Barra Couri
Journal:  Diabetol Metab Syndr       Date:  2009-09-16       Impact factor: 3.320

5.  A Future for Autologous Hematopoietic Stem Cell Transplantation in Type 1 Diabetes.

Authors:  Kayleigh M van Megen; Ernst-Jan T van 't Wout; Stephen J Forman; Bart O Roep
Journal:  Front Immunol       Date:  2018-04-06       Impact factor: 7.561
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.